Pending further clinical trials, cisplatin plus gemcitabine is considered the reference standard first-line agent for patients with unresectable, metastatic, or recurrent bile duct cancer. The results of the TOPAZ-1 trial suggest that a checkpoint inhibitor, durvalumab, will become a standard-of-care ...
The modernized ClinicalTrials.gov public website became the primary site in June 2023. We worked to clarify the purpose of the site, added more plain language, improved search, implemented an overall design that makes clinical study pages easier to read, and optimized for mobile device experience...
Reports that the first United States clinical trial of the herb St. John's wort will be conducted to study its efficacy for treating depression. Trial's sources of funding; St. John's wort called Hypericum; Popularity of herb in Europe, especially Germany; Research to be led by Duke ...
参考 ^https://www.fda.gov/regulatory-information/search-fda-guidance-documents/establishment-and-oper...
clinicaltrials.gov search termsNumber of resultsNumber of completed trialsNumber of trials currently recruiting COVID-19 or SARS-CoV-24105 completed 5 withdrawn 192 1st row terms + vaccine28015 1st row terms + tocilizumab16010 1st row terms + hydroxychloroquine61122 ...
Currently, the team researching TEMPOL is planning additional studies on animals to evaluate a potential clinical trial for the drugs used to treat COVID-19. Currently, the NIH is funding a large clinical trial it launched in April to see if existing prescription and over-the-counter medicat...
Todd Morrillwanted teams developing Diagnostics to have a reimbursement strategy fully documented, the necessary IP in place, regulation and technical validation (clinical trial) regime understood and described and the cost structure and financing needs well documented. ...
Researchers funded by the National Institutes of Health (NIH) have launched an effort to evaluate drugs prescribed to treat COVID-19 in infants, children and adolescents across the country. The study leverages an existing clinical trial that examines drugs that are prescribed off-label to children...
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, extended-release niacin to statin treatment in people with heart and va...
Dr. Durbin expects that the trial will take up to one year to complete. For more information, visit ClinicalTrials.gov and search identifierNCT03611946.